April 4, 2024: Suboxone Update

Dismissal of MonoSol from Suboxone Litigation

In a development in the Suboxone litigation on April 4, 2024, MonoSol, a defendant named in some Suboxone claims, was dismissed from the litigation. MonoSol, previously dismissed from antitrust claims involving Suboxone and product hopping, is no longer part of this litigation. This dismissal marks progress in the litigation as focus shifts to the remaining issues and defendants.